Pharmaceutical Technology's Editorial Advisory Board Members - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Editorial Advisory Board

Pharmaceutical Technology North America and Pharmaceutical Technology Europe magazines publish contributed technical articles that undergo a double-blind peer-review process involving members of our distinguished Editorial Advisory Boards (EAB). The EAB are specialists representing various facets of the pharmaceutical industry. EAB members review manuscripts, recommend subject matter and answer questions when they arise.

Pharmaceutical Technology EAB

James P. Agalloco
Agalloco & Associates

Kevin Altria
Associate Director
GlaxoSmithKline R&D

Larry L. Augsburger, PhD
Professor Emeritus
University of Maryland

Reinhard Baumfalk
Head of Systems Development, Biotechnology Division
Sartorius AG

Rafael Beerbohm
Boehringer Ingelheim GmbH

David H. Bergstrom, PhD
Senior Vice President, Pharmaceutical Development & Corporate Quality Assurance Antares Pharma, Inc.

Gabriele Betz
Head of the Industrial Pharmacy Lab
University of Basel

Phil Borman
QbD Lead & Data Management & Analysis Manager

Rory Budihandojo
Director, Quality and EHS Audit
Boehringer Ingelheim Shanghai Pharmaceuticals

Christopher Burgess
Managing Director
Burgess Analytical Consultancy

Todd L. Cecil
Vice-President, Compendial Science,
United States Pharmacopeia

Metin Çelik, PhD
President, Pharmaceutical
Technologies International (PTI)

Zak T. Chowhan, PhD
Consultant, Pharmaceutical

Suggy S. Chrai, PhD
President and CEO
Chrai Associates, Inc.

Roger Dabbah, PhD
Principal Consultant,
Tri-Intersect Solutions

Ryan F. Donnelly
Lecturer in Pharmaceutics
Queens University Belfast

Tim Freeman
Managing Director
Freeman Technology

Sanjay Garg, PhD
Professor, Pharmaceutical Sciences
University of South Australia

Filipe Gaspar
Director of Drug Product Technology

Sharon Grimster
Vice President, Development
F Star

Anne Marie Healy
Lecturer in Pharmaceutics
University of Dublin

R. Gary Hollenbeck, PhD
Chief Scientific Officer,
UPM Pharmaceuticals

Deirdre Hurley
Senior Director, Plant
Helsinn Birex Pharmaceuticals Ltd

Ruey-ching (Richard) Hwang, PhD
Senior Director,
Pharmaceutical Sciences
Pfizer Global R&D

Makarand Jawadekar
Independent Consultant

Henrik Johanning
Senior Vice President, Compliance
QAtor A/S

Mansoor A. Khan, PhD

Marina Levina
Global Manager, Product Development

Russell E. Madsen
The Williamsburg Group, LLC

Heidi M. Mansour, PhD, RPh
University of Arizona
College of Pharmacy

Roberto Margarita
Business Development Leader
Cordon Pharma

Luigi G. Martini
Chair of Pharmaceutical Innovation
King's College London

Thomas Menzel
Menzel Fluid Solutions AG

Jim Miller
President, PharmSource Information Services
Outsourcing Report

Colin Minchom, PhD
Vice-Presidnet, Particle Design

Cliff Mintz
President and Founder
BioInsights Inc

Christine Moore
Deputy Director for Science and Policy
Office of New Drug Quality Assessment, CDER, FDA

R. Christian Moreton, PhD
Pharmaceutical Sciences
FinnBrit Consulting

Fernando J. Muzzio, PhD
Director, NSF Engineering Research Center on Structured Organic Particulate Systems, Department of Chemical and Biochemical
Rutgers University

Moheb M. Nasr, PhD
Vice-President, CMC Regulatory Strategy
Global Regulatory Affairs, GlaxoSmithKline

Ian Pearson
Executive General Manager-Consulting
Derell Consultants

Garnet E. Peck, PhD
Professor Emeritus of Industrial Pharmacy
Purdue University

Tim Peterson
Transdermal Product Development Leader
Drug Delivery Systems Division, 3M

John Pritchard
Technical Director
Philips Respironics

Thomas Rades
Professor, Research Chair in Formulation Design and Drug Delivery
University of Copenhagen

Jean Paul Remon
Full Professor of Pharmaceutical Technology
Ghent University, Belguim

Rodolfo Romañach
Professor of Chemistry
University of Puerto Rico

Beatriz San Martin
Senior Associate
Field Fisher Waterhouse LLP

Wendy Saffel-Clemmer
Director, Research,
BioPharma Solutions

Gurvinder Singh Rekhi, PhD
Senior Director, Pharmaceutical Research,

Siegfried Schmitt
Principal Consultant

Susan J. Schniepp
Vice-President of Quality and
Regulatory Affairs,
Allergy Laboratories, Inc.

David R. Schoneker
Director of Global Regulatory Affairs, Colorcon

Eric B. Sheinin, PhD
Sheinin and Associates

Stane Srcic
University of Ljubljana, Solvenia

Aloka Srinivasan
Principal Consultant
PARAXEL International

Heinz Sucker, PhD
Professor Emeritus
Pharmaceutical Institute,
University of Bern

Scott Sutton, PhD
Microbiology Network

Griet Van Vaerenbergh
GEA Process Engineering

Benoît Verjans
Chief Commercial Officer
Aseptic Technologies

Andreas Weiler
Global Technical Sales Manager

Tony Wright




View Pharmaceutical Technology's Sourcing and Management Community of Experts


LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
Click here